Psoriatic arthritis: update on pathophysiology, assessment and management.
about
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds EnRelationships between Adipose Tissue and Psoriasis, with or without ArthritisManaging patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasisNew targets in psoriatic arthritisRationale and early clinical data on IL-17 blockade in psoriasis.Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag health study (HUNT).Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.Emerging roles for TNIP1 in regulating post-receptor signalingPrevalence of acute and chronic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infectious events in psoriComparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registryMeasuring disease activity in psoriatic arthritis.Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world settingPrevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study.The balance of tissue repair and remodeling in chronic arthritis.Burden of disease: psoriasis and psoriatic arthritis.Certolizumab pegol for the treatment of psoriatic arthritis.Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis.Secukinumab: A Review in Psoriatic Arthritis.Secukinumab for the treatment of psoriatic arthritis.Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort.Gender specific differences in patients with psoriatic arthritis.Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients.Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors.The performance of psoriatic arthritis classification criteria in Turkish patients with psoriatic arthritis.Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: a high-resolution computed tomography and radiography follow-up study during adalimumab therapy.The Role of Autoantibodies in Bone Metabolism and Bone Loss.Long-term effects of a nurse-led group and individual patient education programme for patients with chronic inflammatory polyarthritis - a randomised controlled trial.Ultrasonographic evaluation of femoral cartilage thickness in patients with psoriatic arthritis.[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German].Characterisation of hand small joints arthropathy using high-resolution MRI--limited discrimination between osteoarthritis and psoriatic arthritis.Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?Tofacitinib in psoriatic arthritis.
P2860
Q26862017-A087D51F-0692-4B7E-919A-B6D5002E4BEBQ27025534-6541D1DC-FC1A-41A9-B970-416744332F7EQ27693878-85244BD0-AF9F-4A8A-8210-8006052B6F4BQ28069592-FE3B181B-3621-4C60-9045-FF3BFFF4108FQ30658185-E3439255-8160-42F9-B1D2-D1CDC4A55C8EQ30662573-9F4B0222-CBEC-4DDA-B83C-595861860528Q34144256-F8ACC8E6-0A5C-4636-B8BB-CA58DA6F6535Q35959559-63E2ED63-93E6-4D48-B9B5-29645999E9FAQ36003961-1DB5FECF-D488-4B14-9BD4-FF6E88B63607Q36412603-6FFCF219-1E59-4938-9533-B94534CB193EQ36472687-B83471A5-1A64-4582-8472-67AF629FFE7AQ36520126-8DE3BE41-AAB1-4CC0-9B39-38242B19DAECQ37221862-AB298747-0BBF-4A02-A892-2997D0C261ADQ37717810-2C7B4458-D07C-4B57-8049-366FA99B8D8AQ37947117-FB142843-F242-4017-86C8-371DCE8B1C45Q38114850-0B18929F-17CA-4C0A-BE2C-4449E820BF38Q38344194-42B7EDBC-5A37-43CC-94E8-54DF351BAC58Q38416536-E0552332-736B-44BD-A53A-9C06D9985201Q38864743-ED97EDE7-18E8-4834-B41A-1DA1FEC616F4Q38934405-C3F31826-4EBF-4266-8AF5-1EAB1D12CA06Q39367830-E5FAC6E4-0B0D-46F0-9A07-D39D0AD5E300Q40651714-0F467BDB-5761-4E2B-94CC-170FDA716D0FQ41134931-31921AE7-D1EB-4BF8-A8CB-577E1B87D596Q42703805-2A8AE68D-C4EF-4731-9772-A09B879C8738Q45391248-05269067-6E49-4AAC-82A7-9AC76B0CAD7CQ46134997-D894B4F3-06ED-44BE-9D38-8308A9214525Q46876696-CC0EF959-BF89-4B16-8BC3-3170489910FAQ47331159-0B7C2AA3-36A1-4FB8-87E4-5946EB4E2A97Q48447140-F95CDAA3-6366-4B1A-8970-E7449CAE7B71Q50920770-31B93B92-92E2-42BB-AC43-E81126D42B8DQ52849042-48C6D8DF-7B70-4E54-AFE2-DA3D10646449Q52885284-F119355B-018B-484B-AF7C-D7988C981967Q54162420-09F71EB1-2CDD-4021-9559-65378F5EB2A9Q54988148-6B5B0C46-14B0-47AB-9B92-54AF448DA860
P2860
Psoriatic arthritis: update on pathophysiology, assessment and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Psoriatic arthritis: update on pathophysiology, assessment and management.
@en
Psoriatic arthritis: update on pathophysiology, assessment and management.
@nl
type
label
Psoriatic arthritis: update on pathophysiology, assessment and management.
@en
Psoriatic arthritis: update on pathophysiology, assessment and management.
@nl
prefLabel
Psoriatic arthritis: update on pathophysiology, assessment and management.
@en
Psoriatic arthritis: update on pathophysiology, assessment and management.
@nl
P356
P1476
Psoriatic arthritis: update on pathophysiology, assessment and management.
@en
P2093
Philip J Mease
P304
P356
10.1136/ARD.2010.140582
P407
P478
70 Suppl 1
P577
2011-03-01T00:00:00Z